In a groundbreaking move, Merck and the Medicines Patent Pool ink a licensing deal for a COVID-19 pill

October 27, 2021 |
U.S. drug company Merck to share license for experimental covid-19 treatment with non-profit
Merck expands manufacturing for molnupiravir. But questions remain.
Related Posts
Access to Medicines

Pharma’s alleged “brea...
PEPFAR Watch

PEPFAR is Rolling the Cloc...
Access to Medicines

Pharma Pricing Secrecy Run...